Tall women, turnips and latte-drinking mice
A round up of the health news headlines on Wednesday 4 April
Taller women have a slightly higher risk of ovarian cancer, reports the BBC. Research published in the PLoS Medicine journal suggests a slight increase in the risk of developing ovarian cancer for every 5cm increase in height (taking into account other factors such as age, smoking, and alcohol consumption).
Previous studies have suggested a link, but there has been conflicting evidence. The latest research looked at 47 epidemiological studies in 14 countries, including 25,000 women with ovarian cancer and more than 80,000 women without ovarian cancer.
Patients with metal-on-metal hip replacements are at no greater risk of cancer than those who do not have them, reports the Daily Telegraph.
A study of more than 40,000 patients found no evidence to suggest that the replacement hips raise the risk of cancer, although researchers said that long-term analysis is needed to confirm they are safe.
The authors of the study, which was published in the British Medical Journal, said their findings showed the risk of cancer for hip replacement patients is relatively low.
Women diagnosed with breast cancer are more likely to survive if they eat their greens, reports the Daily Mail. A Chinese study found a link between higher consumption of cruciferous vegetables such as cabbages, broccoli and turnips, and reduced breast cancer death rates.
Researchers followed the progress of almost 5,000 women for five years and found those that ate more cruciferous vegetables during the first three years after diagnosis; the less likely they were to die.
As consumption increased, the chances of dying from breast cancer fell by between 22% and 62%. Breast cancer recurrence risk also decreased, by 21% and 35%.
Drinking coffee after exercise can help to ward off skin cancer … er, in mice … the Daily Mail reports.
A study conducted by the Rutgers Ernest Mario School of Pharmacy in New Jersey found that the combination of caffeine and exercise reduced the number of skin tumours in cancer-prone mice by 62%.
Study leader Dr Yao-Ping Li said: ‘I believe we may extrapolate these findings to humans and anticipate that we would benefit from these combination treatments as well.'